136 related articles for article (PubMed ID: 36646195)
1. Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models.
Hyldbakk A; Fleten KG; Snipstad S; Åslund AKO; Davies CL; Flatmark K; Mørch Y
Nanomedicine; 2023 Feb; 48():102656. PubMed ID: 36646195
[TBL] [Abstract][Full Text] [Related]
2. Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug Delivery.
Fleten KG; Hyldbakk A; Einen C; Benjakul S; Strand BL; Davies CL; Mørch Ý; Flatmark K
Mar Drugs; 2022 Nov; 20(12):. PubMed ID: 36547891
[TBL] [Abstract][Full Text] [Related]
3. Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft.
Fusser M; Øverbye A; Pandya AD; Mørch Ý; Borgos SE; Kildal W; Snipstad S; Sulheim E; Fleten KG; Askautrud HA; Engebraaten O; Flatmark K; Iversen TG; Sandvig K; Skotland T; Mælandsmo GM
J Control Release; 2019 Jan; 293():183-192. PubMed ID: 30529259
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants.
Valsalakumari R; Pandya AD; Prasmickaite L; Kvalvaag A; Myrann AG; Åslund AKO; Kjos MS; Fontecha-Cuenca C; Haroon HB; Ribeiro ARS; Horejs-Hoeck J; Moghimi SM; Mørch Ý; Skotland T; Sandvig K; Mælandsmo GM; Iversen TG
Int J Nanomedicine; 2024; 19():3009-3029. PubMed ID: 38562610
[TBL] [Abstract][Full Text] [Related]
5. Cabazitaxel-loaded poly(alkyl cyanoacrylate) nanoparticles: toxicity and changes in the proteome of breast, colon and prostate cancer cells.
Øverbye A; Torgersen ML; Sønstevold T; Iversen TG; Mørch Ý; Skotland T; Sandvig K
Nanotoxicology; 2021 Sep; 15(7):865-884. PubMed ID: 34047629
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer.
Fan R; Tong A; Li X; Gao X; Mei L; Zhou L; Zhang X; You C; Guo G
Int J Nanomedicine; 2015; 10():7291-305. PubMed ID: 26664119
[TBL] [Abstract][Full Text] [Related]
7. Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis.
Xu S; Fan H; Yin L; Zhang J; Dong A; Deng L; Tang H
Eur J Pharm Biopharm; 2016 Jul; 104():251-9. PubMed ID: 27185379
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Evaluation of a Cabazitaxel Prodrug Using Nanoparticle Delivery for the Treatment of Taxane-Resistant Malignancies.
Xie B; Wan J; Chen X; Han W; Wang H
Mol Cancer Ther; 2020 Mar; 19(3):822-834. PubMed ID: 31848296
[TBL] [Abstract][Full Text] [Related]
9. Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.
Vrignaud P; Sémiond D; Lejeune P; Bouchard H; Calvet L; Combeau C; Riou JF; Commerçon A; Lavelle F; Bissery MC
Clin Cancer Res; 2013 Jun; 19(11):2973-83. PubMed ID: 23589177
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel cyanoacrylate monomers for use in nanoparticle drug delivery systems prepared by miniemulsion polymerisation - A multistep screening approach.
Hyldbakk A; Mørch Y; Snipstad S; Åslund AKO; Klinkenberg G; Nakstad VT; Wågbø AM; Schmid R; Molesworth PP
Int J Pharm X; 2022 Dec; 4():100124. PubMed ID: 35898812
[TBL] [Abstract][Full Text] [Related]
11. Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.
Sémiond D; Sidhu SS; Bissery MC; Vrignaud P
Cancer Chemother Pharmacol; 2013 Sep; 72(3):515-28. PubMed ID: 23820961
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis.
Fan R; Wang Y; Han B; Luo Y; Zhou L; Peng X; Wu M; Zheng Y; Guo G
Int J Biol Macromol; 2014 Aug; 69():100-7. PubMed ID: 24854212
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound Improves the Delivery and Therapeutic Effect of Nanoparticle-Stabilized Microbubbles in Breast Cancer Xenografts.
Snipstad S; Berg S; Mørch Ý; Bjørkøy A; Sulheim E; Hansen R; Grimstad I; van Wamel A; Maaland AF; Torp SH; Davies CL
Ultrasound Med Biol; 2017 Nov; 43(11):2651-2669. PubMed ID: 28781149
[TBL] [Abstract][Full Text] [Related]
15. Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy.
Sun Y; Zhao Y; Teng S; Hao F; Zhang H; Meng F; Zhao X; Zheng X; Bi Y; Yao Y; Lee RJ; Teng L
Int J Nanomedicine; 2019; 14():135-148. PubMed ID: 30613142
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination.
de Bree E; Rosing H; Michalakis J; Romanos J; Relakis K; Theodoropoulos PA; Beijnen JH; Georgoulias V; Tsiftsis DD
Eur J Surg Oncol; 2006 Aug; 32(6):666-70. PubMed ID: 16618534
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model.
Marchettini P; Stuart OA; Mohamed F; Yoo D; Sugarbaker PH
Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555
[TBL] [Abstract][Full Text] [Related]
18. Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancer.
Wan J; Huang L; Cheng J; Qi H; Jin J; Wang H
Theranostics; 2021; 11(9):4137-4154. PubMed ID: 33754053
[No Abstract] [Full Text] [Related]
19. Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer.
Qu N; Lee RJ; Sun Y; Cai G; Wang J; Wang M; Lu J; Meng Q; Teng L; Wang D; Teng L
Int J Nanomedicine; 2016; 11():3451-9. PubMed ID: 27555767
[TBL] [Abstract][Full Text] [Related]
20. The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis.
Kim J; Shim MK; Cho YJ; Jeon S; Moon Y; Choi J; Kim J; Lee J; Lee JW; Kim K
Biomaterials; 2021 Dec; 279():121189. PubMed ID: 34695659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
